DexCom
DXCM
DXCM
289 hedge funds and large institutions have $8.85B invested in DexCom in 2018 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 99 increasing their positions, 101 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 101
52.73% less ownership
Funds ownership: 476.1% → 423.38% (-53%)
Holders
289
Holding in Top 10
5
Calls
$30.5M
Puts
$24.6M
Top Buyers
| 1 | +$67M | |
| 2 | +$66.2M | |
| 3 | +$58.4M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$46.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$45.3M |
Top Sellers
| 1 | -$318M | |
| 2 | -$235M | |
| 3 | -$234M | |
| 4 |
Goldman Sachs
New York
|
-$85.2M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$70.6M |